Blood Donor CVD 5000 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Blood Donor CVD 5000 — Stella

Recruiting

Back to Risk Reduction trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore, Maryland

Key details

Phase

Post-approval study

Sponsor

University of Maryland, Baltimore

Enrollment target

~150 participants

Started

January 2004

Primary completion

June 2030

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov